Lin TY - Search Results

1

Nanotechnology in bladder cancer: current state of development and clinical practice.

Tomlinson B, Lin TY, Dall'Era M, Pan CX. Tomlinson B, et al. Among authors: lin ty. Nanomedicine (Lond). 2015;10(7):1189-201. doi: 10.2217/nnm.14.212. Nanomedicine (Lond). 2015. PMID: 25929573 Free PMC article. Review.

2

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand.

Lin TY, Zhang H, Wang S, Xie L, Li B, Rodriguez CO Jr, de Vere White R, Pan CX. Lin TY, et al. Mol Cancer. 2011 Jan 27;10(1):9. doi: 10.1186/1476-4598-10-9. Mol Cancer. 2011. PMID: 21272294 Free PMC article.

3

Multifunctional targeting micelle nanocarriers with both imaging and therapeutic potential for bladder cancer.

Lin TY, Zhang H, Luo J, Li Y, Gao T, Lara PN Jr, de Vere White R, Lam KS, Pan CX. Lin TY, et al. Int J Nanomedicine. 2012;7:2793-804. doi: 10.2147/IJN.S27734. Epub 2012 Jun 6. Int J Nanomedicine. 2012. PMID: 22745542 Free PMC article.

4

Tumor-targeting multifunctional micelles for imaging and chemotherapy of advanced bladder cancer.

Lin TY, Li YP, Zhang H, Luo J, Goodwin N, Gao T, White Rde V, Lam KS, Pan CX. Lin TY, et al. Nanomedicine (Lond). 2013 Aug;8(8):1239-51. doi: 10.2217/nnm.12.150. Epub 2012 Dec 2. Nanomedicine (Lond). 2013. PMID: 23199207 Free PMC article.

5

Nanomicelle formulation modifies the pharmacokinetic profiles and cardiac toxicity of daunorubicin.

Zhang H, Li Y, Lin TY, Xiao K, Haddad AS, Henderson PT, Jonas BA, Chen M, Xiao W, Liu R, Lam KS, Pan CX. Zhang H, et al. Among authors: lin ty. Nanomedicine (Lond). 2014;9(12):1807-20. doi: 10.2217/nnm.14.44. Epub 2014 Mar 17. Nanomedicine (Lond). 2014. PMID: 24628688 Free PMC article.

6

A smart and versatile theranostic nanomedicine platform based on nanoporphyrin.

Li Y, Lin TY, Luo Y, Liu Q, Xiao W, Guo W, Lac D, Zhang H, Feng C, Wachsmann-Hogiu S, Walton JH, Cherry SR, Rowland DJ, Kukis D, Pan C, Lam KS. Li Y, et al. Among authors: lin ty. Nat Commun. 2014 Aug 26;5:4712. doi: 10.1038/ncomms5712. Nat Commun. 2014. PMID: 25158161 Free PMC article.

7

Nanomedicine in veterinary oncology.

Lin TY, Rodriguez CO Jr, Li Y. Lin TY, et al. Vet J. 2015 Aug;205(2):189-97. doi: 10.1016/j.tvjl.2015.02.015. Epub 2015 Mar 3. Vet J. 2015. PMID: 25862394 Review.

8

Development and Characterization of Bladder Cancer Patient-Derived Xenografts for Molecularly Guided Targeted Therapy.

Pan CX, Zhang H, Tepper CG, Lin TY, Davis RR, Keck J, Ghosh PM, Gill P, Airhart S, Bult C, Gandara DR, Liu E, de Vere White RW. Pan CX, et al. Among authors: lin ty. PLoS One. 2015 Aug 13;10(8):e0134346. doi: 10.1371/journal.pone.0134346. eCollection 2015. PLoS One. 2015. PMID: 26270481 Free PMC article. Clinical Trial.

9

Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity.

Jiang S, Pan AW, Lin TY, Zhang H, Malfatti M, Turteltaub K, Henderson PT, Pan CX. Jiang S, et al. Among authors: lin ty. Chem Res Toxicol. 2015 Dec 21;28(12):2250-2. doi: 10.1021/acs.chemrestox.5b00422. Epub 2015 Nov 11. Chem Res Toxicol. 2015. PMID: 26544157 Free PMC article.

10

Molecular Dissection of Induced Platinum Resistance through Functional and Gene Expression Analysis in a Cell Culture Model of Bladder Cancer.

Wang S, Zhang H, Scharadin TM, Zimmermann M, Hu B, Pan AW, Vinall R, Lin TY, Cimino G, Chain P, Vuyisich M, Gleasner C, Mcmurry K, Malfatti M, Turteltaub K, de Vere White R, Pan CX, Henderson PT. Wang S, et al. Among authors: lin ty. PLoS One. 2016 Jan 22;11(1):e0146256. doi: 10.1371/journal.pone.0146256. eCollection 2016. PLoS One. 2016. PMID: 26799320 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

2,263 results

Search Page

Filters